Repligen (RGEN) Reports Q4 Loss of $0.09, Misses by 3c
RGEN Hot Sheet
Financial Fact:Cost of product revenue: 2.09M
Today's EPS Names:
TARO, BRLI, TLB, More
Repligen Corporation (Nasdaq: RGEN) reports Q4 loss of $0.09, 3 cents lower than the analyst estimate of ($0.06). Revenue for the quarter was $4.59 million, versus the consensus of $5 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Tiffany & Co. (TIF) Misses Q1 EPS Views; Lowers FY12 EPS, Revs Growth Outlook
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
